Efficacy and safety of peginterferon α -2a and entecavir tenofovir in the treatment of chronic hepatitis b genotype c

HIGHLIGHTS

• who: Jiao Yu from the Department of Infection, Wuxi Mingci Cardiovascular Hospital, Wuxi, China have published the paper: Efficacy and Safety of Peginterferon u03b1 -2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C, in the Journal: Contrast Media and Molecular Imaging of 28/09/2022
• what: In this work, the clinical application value of PEG-IFN u03b1-2a and entecavir or tenofovir in the treatment of patients with CHB genotype C is explored.
• how: This article discusses the clinical value of Pegylated Interferon (PEG-IFN) u03b1-2a combined with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.